Clonil Intas Pharmaceuticals Ltd. को ब्रान्ड परिवार हो, नेपालमा बिक्री हुन्छ। NepalDoc सूचीमा यसका ३ वटा उत्पादन छन्, सबै Clomipramine Hydrochloride।
Clomipramine hydrochloride capsules, USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The obsessions or compulsions must cause marked distress, be time-consuming, or significantly interfere with social or occupational functioning, in order to meet the DSM-III-R (circa 1989) diagnosis of OCD.
From the U.S. FDA-approved label for Clomipramine Hydrochloride. Full label: DailyMed.
Clomipramine hydrochloride capsules, USP is indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD). The obsessions or compulsions must cause marked distress, be time-consuming, or significantly interfere with social or occupational functioning, in order to meet the DSM-III-R (circa 1989) diagnosis of OCD. Obsessions are recurrent, persistent ideas, thoughts, images, or impulses that are ego-dystonic. Compulsions are repetitive, purposeful, and intentional behaviors performed in response to an obsession or in a stereotyped fashion, and are recognized by the person as excessive or unreasonable. The effectiveness of clomipramine hydrochloride capsules, USP for the treatment of OCD was demonstrated in multicenter, placebo-controlled, parallel-group studies, including two 10-week studies in adults and one 8-week study in children and adolescents 10 to 17 years of age. Patients in all studies had moderate-to-severe OCD (DSM-III), with mean baseline ratings on the Yale-Brown Obsessive Compulsive Scale (YBOCS) ranging from 26 to 28 and a mean baseline rating of 10 on the NIMH Clinical Global Obsessive Compulsive Scale (NIMH-OC).
From the U.S. FDA-approved label for Clomipramine Hydrochloride. Full label: DailyMed.
The treatment regimens described below are based on those used in controlled clinical trials of clomipramine hydrochloride capsules, USP in 520 adults, and 91 children and adolescents with OCD. During initial titration, clomipramine hydrochloride capsules, USP should be given in divided doses with meals to reduce gastrointestinal side effects. The goal of this initial titration phase is to minimize side effects by permitting tolerance to side effects to develop or allowing the patient time to adapt if tolerance does not develop.
Directions from the U.S. FDA-approved label for Clomipramine Hydrochloride — your doctor or pharmacist may advise differently.
Clomipramine hydrochloride capsules, USP are contraindicated in patients with a history of hypersensitivity to clomipramine hydrochloride capsules, USP or other tricyclic antidepressants. Monoamine Oxidase Inhibitors (MAOIs) The use of MAOIs intended to treat psychiatric disorders with clomipramine hydrochloride capsules, USP or within 14 days of stopping treatment with clomipramine hydrochloride capsules, USP are contraindicated because of an increased risk of serotonin syndrome.
Excerpt from the U.S. FDA-approved label for Clomipramine Hydrochloride. Talk to a pharmacist or doctor before use.
Clinical Worsening and Suicide Risk Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs. Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide.
Warnings and precautions excerpt from the U.S. FDA-approved label for Clomipramine Hydrochloride — not a complete list. Talk to a pharmacist or doctor before use.
Commonly Observed The most commonly observed adverse events associated with the use of clomipramine hydrochloride capsules, USP and not seen at an equivalent incidence among placebo-treated patients were gastrointestinal complaints, including dry mouth, constipation, nausea, dyspepsia, and anorexia; nervous system complaints, including somnolence, tremor, dizziness, nervousness, and myoclonus;
Excerpt from the U.S. FDA-approved label for Clomipramine Hydrochloride — not a complete list. Talk to a pharmacist or doctor about side effects.
९ ब्रान्ड · ३ निर्माता — NepalDoc सूचीमा — पूरै Clomipramine Hydrochloride गाइड हेर्नुहोस् →
Storage – Store at 20° to 25°C (68° to 77°F). Protect from moisture.
Storage information from the U.S. FDA-approved label for Clomipramine Hydrochloride.
Clonil के हो?
Clonil 50mg Tablet भनेको Clomipramine Hydrochloride औषधि हो, Intas Pharmaceuticals Ltd. ले बनाएको। यो 50mg Tablet रूपमा पाइन्छ।
Clonil को सामान्य नाम के हो?
Clonil को सामान्य नाम Clomipramine Hydrochloride हो।
नेपालमा Clomipramine Hydrochloride का कुन कुन ब्रान्ड उपलब्ध छन्?
NepalDoc सूचीमा Clomipramine Hydrochloride का ९ वटा ब्रान्ड छन्, ३ निर्माताबाट — जसमा Clofranil 10mg Tablet, Clofranil 25mg Tablet, Clofranil 50mg Tablet, Clomip 10mg Tablet, Clomip 25mg Tablet, Clomip 50mg Tablet पर्छन्।
Clonil को मूल्य नेपालमा कति हो?
NepalDoc ले औषधिको मूल्य सूचीबद्ध गर्दैन। मूल्य हरेक फार्मेसीले आफैं तय गर्छ र समयसँगै परिवर्तन हुन्छ — यो पृष्ठले नेपालमा बिक्री हुने ब्रान्ड, यसको सामान्य नाम, निर्माता, शक्ति र प्याक विवरण पुष्टि गर्छ, ताकि तपाईं आफ्नो फार्मेसीमा मूल्य विश्वस्त भएर सोध्न सक्नुहोस्।
यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधिको विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ — प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग औषधि, शक्ति र मात्रा पुष्टि गर्नुहोस्। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।
नेपालडकका सबै खण्ड, एकै ठाउँमा।